Informed or Influenced?: An Overview of the GLP-1 Receptor Agonist MDL and Why the Excessive Direct to Consumer Advertising of These Drugs May Warrant An Exception to the Learned Intermediary Doctrine
Written by Samantha Farpour, L’26 Introduction One-in-eight, or about 13%, of American adults have used a GLP-1 receptor agonist drug (GLP-1 RA), with higher percentages of younger adults using the drugs primarily for weight loss as compared to adults ages sixty-five years and older.[1] The prevalence of GLP-1 RAs is such that Jan Hatzius, chief economist at Goldman Sachs, predicted a 1% boost (amounting to several … Continue reading Informed or Influenced?: An Overview of the GLP-1 Receptor Agonist MDL and Why the Excessive Direct to Consumer Advertising of These Drugs May Warrant An Exception to the Learned Intermediary Doctrine